<SEC-DOCUMENT>0001178913-25-003447.txt : 20250930
<SEC-HEADER>0001178913-25-003447.hdr.sgml : 20250930
<ACCEPTANCE-DATETIME>20250930160010
ACCESSION NUMBER:		0001178913-25-003447
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250930
FILED AS OF DATE:		20250930
DATE AS OF CHANGE:		20250930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRINITY BIOTECH PLC
		CENTRAL INDEX KEY:			0000888721
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22320
		FILM NUMBER:		251360313

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		IDA BUSINESS PARK
		STREET 2:		BRAY
		CITY:			WICKLOW
		PROVINCE COUNTRY:   	L2
		BUSINESS PHONE:		01135312955111

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		IDA BUSINESS PARK
		STREET 2:		BRAY
		CITY:			WICKLOW
		PROVINCE COUNTRY:   	L2
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2533833.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.8.1.5328
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><br>
    <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 14pt;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Washington, D.C.&#160; 20549</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 15%; color: #000000;"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 14pt;">F O R M&#160;6-K</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the month of September 2025</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 16pt;">TRINITY BIOTECH PLC</div>
    <div style="text-align: center; line-height: 1.25;">(Name of Registrant)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;">IDA Business Park</div>
    <div style="text-align: center; line-height: 1.25;">Bray, Co. Wicklow, Ireland</div>
    <div style="text-align: center; line-height: 1.25;">(Address of Principal Executive Office)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Indicate by check mark whether the registrant files or will file annual reports under cover of</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> Form 20-F or Form 40-F.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Form 20-F <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font>&#160;&#160;&#160; Form 40-F <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <br>
    <div style="line-height: 1.25; font-weight: bold;">This Form 6-K is being incorporated by reference into our Registration Statements on Form S-8 (File Nos. 333-182279, 333-195232 and 333-253070).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Trinity Biotech plc Announces Results of Annual General Meeting</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">At the annual general meeting (the &#8220;Meeting&#8221;) of the Company held on September 30 2025, shareholders approved all of the resolutions proposed by the requisite majorities and with a minimum approval of 93% of votes cast.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">The resolutions (the text of which is more fully set out in the notice of meeting dated September 4 2025) were as follows:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8c62f90777ca4aebb66b5ef30eab2e1b">

        <tr>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>To re-appoint Grant Thornton as statutory auditor of the Company to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3594aa2077184174a52e314cf90e66a6">

        <tr>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>To authorise the board of directors to fix the statutory auditors&#8217; remuneration.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1372c22fd3e944dd88b0f3aa8af04e8f">

        <tr>
          <td style="width: 18pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>To reduce the nominal (par) value of each of the Company&#8217;s A Ordinary Shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z14747cb7929640c98d0801ec8b59f89d">

        <tr>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>To increase the Company&#8217;s authorised share capital.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z521d15700c8e4f82b8ee2e9c4d5b8439">

        <tr>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div>To refresh the board of directors&#8217; authority to allot and issue new shares in the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z35df0b003d2a440ba798f56c3cac7a87">

        <tr>
          <td style="width: 18pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top;">
            <div>To refresh the board of directors&#8217; authority to allot and issue new shares for cash without applying Irish statutory pre-emption rights.</div>
          </td>
        </tr>

    </table>
    <br>
    <div style="line-height: 1.25;">Jim Walsh retired by rotation from the Company&#8217;s board of directors at the Meeting in accordance with the Company&#8217;s constitution.&#160;The Company would like to express its sincere gratitude to Jim for his many contributions
      and his commitment over more than 30 years of service.&#160; The Company is also grateful that Jim has agreed to continue to support the Company&#8217;s management team as a Scientific Advisor.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25;">SIGNATURES</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zcc2cebd8d11b45c3883817bd93f13371">

        <tr>
          <td style="width: 49.8%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top; border-bottom: 2px solid black;">
            <div style="line-height: 1.25;">TRINITY BIOTECH PLC</div>
          </td>
          <td style="width: 19.8%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.8%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.8%; vertical-align: top;">
            <div style="line-height: 1.25;">Trinity Biotech plc</div>
          </td>
          <td style="width: 19.8%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.8%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.8%; vertical-align: top;">
            <div style="line-height: 1.25;">(Registrant)</div>
          </td>
          <td style="width: 19.8%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.8%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.8%; vertical-align: top;">&#160;</td>
          <td style="width: 19.8%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.8%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div style="line-height: 1.25;">By:</div>
          </td>
          <td style="width: 26.8%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">/s/ Susan O&#8217;Connor</div>
          </td>
          <td style="width: 19.8%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.8%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 26.8%; vertical-align: top;">
            <div style="line-height: 1.25;">Susan O&#8217;Connor</div>
            <div style="line-height: 1.25;">Chief Financial Officer</div>
          </td>
          <td style="width: 19.8%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Date:&#160; September 30, 2025</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
